Chance Pharmaceuticals is a clinical-stage biotechnology company focusing on discovering, developing and commercializing transformative inhalation therapies for the world’s most debilitating diseases Founded in 2015 by a team of passionate and experienced experts in inhalation therapy, our vision is to harness the potential of inhalation therapy to improve and transform the lives of people living with the diseases for which more treatment options are needed.